Jefferies Maintains Buy on Eli Lilly and Co, Raises Price Target to $957
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Akash Tewari maintains a Buy rating on Eli Lilly and Co (NYSE:LLY) and raises the price target from $925 to $957.
June 07, 2024 | 5:26 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Jefferies analyst Akash Tewari maintains a Buy rating on Eli Lilly and Co (NYSE:LLY) and raises the price target from $925 to $957.
The raised price target and maintained Buy rating from a reputable analyst at Jefferies is likely to positively impact investor sentiment and drive short-term price appreciation for Eli Lilly and Co.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100